Delivery Order SPE2DE24DA017-SPE2D625F4EAS
- Not listed
- On June 27, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,621.02 to Arthrex Inc. for FiberTag TightRope II with Internal Brace orthopedic medical devices. This fixed-price delivery order with economic price adjustment represents a continuation of services under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and spanning June 2024 through September 2029. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,746.18 on June 5, 2025, for FiberTag Tightrope II with InternalBrace orthopedic surgical products. This fixed-price delivery order with economic price adjustment is set to be completed by June 16, 2025, and will be delivered to Naples, Florida. The award was issued through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a $20,141.80 fixed-price delivery order to Arthrex Inc. on August 5, 2025, for FiberTag Tightrope II with InternalBrace orthopedic surgical products. This delivery order, with an ultimate completion date of August 8, 2025, will be performed in Naples, Florida, where Arthrex maintains its global headquarters. The award utilized no set-aside designation, reflecting Arthrex's strong competitive positioning in the federal orthopedic medical...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, was awarded a delivery order valued at $1,452.66 by the Defense Logistics Agency's Medical Supply Chain on July 29, 2025, for FiberTag TightRope II with InternalBrace surgical products. This fixed-price delivery order with economic price adjustment represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and extending through...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,243.44 on April 19, 2025, for FiberTag TightRope II with InternalBrace products. This fixed-price delivery order with economic price adjustment pricing is scheduled for completion by April 29, 2025, and will be performed in Naples, Florida. The award was issued through the Defense Logistics Agency's Medical Supply Chain, which serves the Department of...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, has been awarded a delivery order valued at $1,336.50 for FIBERTAG TIGHTROPE II ABS, a specialized orthopedic surgical product. This fixed-price delivery order with economic price adjustment was issued on April 24, 2025, with an ultimate completion date of April 29, 2025. The contract was funded by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency, and is not...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $12,210.00 to Arthrex Inc., a leading orthopedic medical device manufacturer based in Naples, Florida. This fixed-price contract with economic price adjustment is for the Fibertak Suture Bridge Implant System, an advanced orthopedic surgical technology. The delivery order was issued on August 15, 2025, with an ultimate completion date of August 20, 2025, and will be performed at Arthrex's Naples...
- This delivery order, valued at $3,191.76, was awarded to Arthrex Inc. on September 5, 2025, by the Defense Logistics Agency's Medical Supply Chain on behalf of the Department of Defense. The order is for Fibertak Tightrope II with Internal Brace, an advanced orthopedic surgical implant system used in minimally invasive orthopedic procedures. Arthrex Inc., headquartered in Naples, Florida, is a global leader in minimally invasive orthopedic medical technologies and holds a significant position as...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $8,988.09 by the Defense Logistics Agency's Medical Supply Chain on August 27, 2025. The contract, designated as FIBERTAG TIGHTROPE II ABS, is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 2, 2025. This award was not issued under any small business...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $5,578.55 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, for the FIBERTAG TIGHTROPE II product. The delivery order, which carries an ultimate completion date of September 9, 2025, was awarded without a set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace....
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F4EASDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,787.64 to Arthrex Inc. on September 25, 2025, for the provision of Fibertag Tightrope II with Internal Brace orthopedic surgical devices. This delivery order, which carries a fixed-price contract type with economic price adjustment provisions, is scheduled for completion by September 30, 2025, and will be performed at Arthrex's Naples, Florida location. The award was made without a set-aside designation, reflecting the company's strong competitive position in the federal orthopedic medical device marketplace. Arthrex Inc., a Naples, Florida-headquartered global leader in minimally invasive orthopedic medical technologies, is well-established as a primary supplier to the Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order is issued under Arthrex's comprehensive Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and spanning from June 2024 through September 2029. The company's extensive federal contracting history demonstrates its capability to supply advanced orthopedic surgical implants, instruments, and specialized medical device systems to government healthcare systems nationwide, with particular emphasis on supporting veterans and military personnel requiring orthopedic surgical procedures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 9/25/25 |